Form: 8-K

Current report filing

September 9, 2021

 Exhibit 3.1

 

 

 

CERTIFICATE OF AMENDMENT

 

Business Corporations Act (CQLR, chapter S-31.1)

 

 

 

I attest that the legal person

 

ACASTI PHARMA INC.

 

has modified its articles pursuant to the Business Corporations Act (Québec) to integrate the changes outlined in the attached articles.

 

August 27, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Filed in the register on August 26, 2021 under the

Québec Registration Number 1160589793.

 

 

 

 

(Signed)

Registraire des entreprises

 

 

 

Registraire des entreprises

REZ-909 (2017-04)

 

Page 1 of 1

 

Articles of Amendment

 

 

Business Corporations Act (Québec)

Québec Enterprise Number:

1160589793

 

 

1 Information about the business

 

ACASTI PHARMA INC.

 

Version(s) of the name of the corporation in any other language other than French, if applicable

 

2 Amendment to Articles

 

2.1 Amendment to Name

 

2.2 Other Amendments

 

See Schedule Attached.

 

2.3. Date and Time of certificate, if applicable

 

Date: August 27, 2021 Time:

 

3 Correction of Articles

 

4 Signature

 

Last name and first name of the authorized officer or director:

Janelle D’Alvise

 

 

Electonic signature of:

Janelle D’Alvise

 

 

Reserved for the administration

Reference number of request: 020200085440883

Numeric designation:

 

 

 

 

SCHEDULE TO

 

ARTICLES OF AMENDMENT

 

OF

 

ACASTI PHARMA INC.

(the “Corporation”)

 

As of the date of the issuance of a Certificate of Amendment confirming the present Articles of Amendment, all of the issued and outstanding Class “A” Shares (the “Common Shares”) in the capital of the Corporation are consolidated (the “Consolidation”) on the bases of one (1) post-Consolidation Common Share for every 8 (eight) pre-Consolidation Common Shares (provided that each fractional Common Share that results from the Consolidation shall be rounded to the nearest whole number).